How to Interpret Suicidal Ideation Change With VNS in TRD
How should clinicians interpret suicidal ideation improvement, remission, or worsening during adjunctive VNS treatment in markedly treatment-resistant major depression?
Clinicians considering or managing VNS need to know what pattern of suicidal ideation change is realistic and clinically meaningful. This guide applies to adults with markedly treatment-resistant nonpsychotic major depression, especially those with chronic baseline suicidal ideation rather than acute suicidal crisis.
-
Establish whether meaningful suicidal ideation is present at baseline
Separate patients into those with meaningful baseline suicidal ideation and those without it using the composite suicidal ideation threshold of 3 or higher versus 0 to 2. In the study, treatment effects were interpreted differently for these two groups.
-
For patients with baseline ideation, look for sustained meaningful improvement
In patients starting with meaningful suicidal ideation, interpret benefit as repeated months with a 3-point or greater reduction from baseline rather than expecting dramatic separation at single visits. Active VNS was associated with more months in clinically meaningful improvement across months 3 to 12 than sham VNS, with an odds ratio of 1.43.
-
Expect gradual change rather than an acute antisuicidal effect
Do not frame VNS as an acute intervention for suicidal ideation or suicidal behavior. In the study, both active and sham groups showed substantial decline starting at month 3, and reductions increased over months 3 to 12.
-
Look especially at late-phase remission if baseline ideation was meaningful
For patients who begin with meaningful suicidal ideation, pay particular attention to months 10 to 12 when judging remission. Active VNS was associated with significantly more months in remission than sham during this late period, using the prespecified remission definition of at least a 3-point drop and a current composite score of 2 or lower.
-
Do not overinterpret mean score differences at isolated visits
The study noted that mean composite suicidal ideation differences between active and sham groups were not statistically significant at any individual time point. Interpret VNS benefit as a longitudinal pattern of more time spent improved or in remission, not as a large cross-sectional difference at one visit.
-
For patients without baseline ideation, watch for emergence but expect it to be infrequent
If the patient starts without clinically meaningful suicidal ideation, monitor for a 3-point or greater increase in the composite score as emergence of meaningful ideation. In the study, such emergence was infrequent and did not differ between active and sham VNS.
-
Do not assume VNS worsens suicidal ideation
When patients begin with meaningful suicidal ideation, meaningful worsening was limited in the trial and no meaningful difference between active and sham VNS was identified. The study therefore did not show evidence that active VNS increased suicidal ideation in those with or without baseline ideation.
Clinical Considerations
- The suicidal ideation analyses were exploratory, and the trial was not designed or statistically powered specifically to detect treatment effects on suicidal ideation.
- No correction for multiple comparisons was applied, so reported P values and confidence intervals were descriptive rather than confirmatory.
- These findings are more applicable to chronic suicidal ideation in markedly treatment-resistant unipolar depression than to acute suicidal crisis.
- RECOVER excluded patients with severe suicidal intent or behavior at baseline.
Bottom Line
In markedly treatment-resistant major depression, interpret VNS-related suicidal ideation benefit as gradual, sustained improvement over months, with the clearest remission advantage emerging late in treatment for patients who start with meaningful ideation.
